Group-wide meetings of the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) occur twice a year and are open to researchers affiliated with member institutions, patient advocates who are members of ECOG-ACRIN’s various scientific committees, industry representatives, and invited individuals from external (non-member) organizations. Group meetings are closed to the public.
Content from the Virtual Spring 2021 Group Meeting
The format of our Virtual Spring 2021 Group Meeting was similar to that of our Virtual Fall 2020 Group Meeting. Sessions were open to staff from ECOG-ACRIN member institutions, ECOG-ACRIN advocates, NCI/NIH employees, and invited guests.
We are pleased to offer several pre-recorded educational presentations, geared toward clinical research staff, to download and view on demand. To access the materials, visit the Clinical and Administrative Resources section of the website, where we typically store such information. They will be available during and after the meeting to anyone with member log-in credentials, regardless of meeting attendance.
The desktop/web version of the meeting app is a great resource for registered attendees. Use it to browse sessions, view agendas, connect with other attendees, and more. To access the meeting app on your laptop/desktop, log in with your first name, last name, and the email address you used to register for the meeting.
To use the app on a mobile device, follow these instructions:
Future Group Meetings through 2023
Spring 2022: Chicago, Marriott Downtown Magnificent Mile, May 4-6 (W-F)
Fall 2022: Washington, DC, Renaissance DC Downtown, October 26-28 (W-F)
Spring 2023: Chicago, Marriott Downtown Magnificent Mile, May 3-5 (W-F)
Fall 2023: Washington, DC, Renaissance DC Downtown, October 25-27 (W-F)
Interested in becoming an industry sponsor or exhibitor for a future meeting?
Request a Group Meeting Prospectus from Christina Chink via phone at 215.789.3639 or send an email.
|Active Clinical Trials: Resources|
|NCI-MATCH Information for Researchers|
|ECOG Performance Status|
|Sample Tracking System|